M. Kroes

When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

N. Adlard, S. Montgomery, K. Noon, 2018, Journal of medical economics.

The Relative Efficacy of Treatments in First-Line Management of Newly Diagnosed Chronic Myeloid Leukaemia: Systematic Literature Review and Indirect Comparison.

A. Paine, M. Kroes, A. Zagorska, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A systematic literature review of the burden of pediatric multiple sclerosis in North America and Europe

L. Krupp, M. Kroes, J. Goble, 2019 .

Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK

M. Duddy, K. Gudala, S. Montgomery, 2022, Journal of medical economics.

Second-line single-agent chemotherapy in human epidermal growth factor receptor 2-negative metastatic breast cancer: A systematic review.

D. Rea, F. Puglisi, P. Pronzato, 2016, Cancer treatment reviews.

A Systematic Review of Insulin Adherence Measures in Patients with Diabetes

N. Webb, T. Wisniewski, M. Kroes, 2016, Journal of managed care & specialty pharmacy.

Impact of weight change on quality of life in adults with overweight/obesity in the United States: a systematic review

M. Kroes, Joanna C. Huang, G. Osei-assibey, 2016, Current medical research and opinion.

Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK

N. Aldhouse, M. Chaponda, M. Kroes, 2018, International journal of STD & AIDS.

Transition to secondary progressive multiple sclerosis: The consequences for patients and healthcare systems, a healthcare professional survey

M. Duddy, S. Montgomery, M. Kroes, 2022, Health science reports.

Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis

J. Larkin, J. Cappelleri, I. Tumur, 2013, Expert opinion on pharmacotherapy.

When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

N. Adlard, S. Montgomery, K. Noon, 2018, Journal of medical economics.